A. Brian Mochon
About
A. Brian Mochon is a scholar working on Epidemiology, Clinical Biochemistry and Infectious Diseases.
According to data from OpenAlex, A. Brian Mochon has authored 24 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Clinical Biochemistry and 6 papers in Infectious Diseases. Recurrent topics in A. Brian Mochon's work include Bacterial Identification and Susceptibility Testing (9 papers), Antibiotic Resistance in Bacteria (6 papers) and Streptococcal Infections and Treatments (5 papers). A. Brian Mochon is often cited by papers focused on Bacterial Identification and Susceptibility Testing (9 papers), Antibiotic Resistance in Bacteria (6 papers) and Streptococcal Infections and Treatments (5 papers). A. Brian Mochon collaborates with scholars based in United States, Canada and Australia. A. Brian Mochon's co-authors include Haoping Liu, Michael A. Lewinski, Omai B. Garner, David Ziring, Laura J. Wozniak, Carey‐Ann D. Burnham, Maureen Bythrow, Christine C. Ginocchio, Rebecca Jennemann and Lars F. Westblade and has published in prestigious journals such as Clinical Microbiology Reviews, Clinical Infectious Diseases and Journal of Clinical Microbiology.
In The Last Decade
A. Brian Mochon
23 papers receiving 826 citations
Peers
A. Brian Mochon
Emily K. Crispell United States
Ellen C. Brouwer Netherlands
Matthias Marschal Germany
Bianca Graves Australia
Marta Mollerach Argentina
Fevronia Kolonitsiou Greece
Magali Dodémont Belgium
Michael Malczynski United States
Hidemasa Nakaminami Japan
Tai-Fen Lee Taiwan
Citations per year, relative to A. Brian Mochon A. Brian Mochon (= 1×)
peers
Emily K. Crispell
Countries citing papers authored by A. Brian Mochon
Since
Specialization
Citations
This map shows the geographic impact of A. Brian Mochon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Brian Mochon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Brian Mochon more than expected).
Fields of papers citing papers by A. Brian Mochon
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by A. Brian Mochon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Brian Mochon. The network helps show where A. Brian Mochon may publish in the future.
Co-authorship network of co-authors of A. Brian Mochon
This figure shows the co-authorship network connecting the top 25 collaborators of A. Brian Mochon. A scholar is included among the top collaborators of A. Brian Mochon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Brian Mochon. A. Brian Mochon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Linder, Jeffrey A., Michael E. Watson, Michael R. Wessels, et al.. (2025). 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adults. Clinical Infectious Diseases.
2.
Bobenchik, April M., Robin R. Chamberland, Andrew E. Clark, et al.. (2025). Activity of novel ceftibuten-avibactam, ceftazidime-avibactam, and comparators against a challenge set of Enterobacterales from outpatient centers and nursing homes across the United States (2022–2024). Antimicrobial Agents and Chemotherapy. 69(5). e0186724–e0186724.
3.
Wolk, Donna M., J. Scott Parrott, N. Esther Babady, et al.. (2025). The American Society for Microbiology’s evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis. Clinical Microbiology Reviews. 38(3). e0013724–e0013724.
4.
Asempa, Tomefa E., April M. Bobenchik, Lori Bourassa, et al.. (2023). Antimicrobial Activity of Tebipenem and Comparators against Enterobacterales from diverse Outpatient Centers and Nursing Homes in the United States. International Journal of Antimicrobial Agents. 61(3). 106733–106733.
5.
Bowers, Jolene R., Hayley D. Yaglom, Jane E. Sykes, et al.. (2022). Phylogenomic Placement of American Southwest-Associated Clinical and Veterinary Isolates Expands Evidence for Distinct Cryptococcus gattii VGVI. Microorganisms. 10(8). 1681–1681.
6.
Mochon, A. Brian, et al.. (2016). Telemicrobiology: Focusing on Quality in an Era of Laboratory Consolidation. Clinical Microbiology Newsletter. 38(3). 19–24.
7.
Westblade, Lars F., Omai B. Garner, Karen MacDonald, et al.. (2015). Assessment of Reproducibility of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Bacterial and Yeast Identification. Journal of Clinical Microbiology. 53(7). 2349–2352.
8.
Garner, Omai B., A. Brian Mochon, John A. Branda, et al.. (2013). Multi-centre evaluation of mass spectrometric identification of anaerobic bacteria using the VITEK® MS system. Clinical Microbiology and Infection. 20(4). 335–339.
9.
Mochon, A. Brian, et al.. (2013). Lactobacillus Bacteremia Associated With Probiotic Use in a Pediatric Patient With Ulcerative Colitis. Journal of Clinical Gastroenterology. 47(5). 437–439.
10.
Manji, Ryhana, Maureen Bythrow, John A. Branda, et al.. (2013). Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli. European Journal of Clinical Microbiology & Infectious Diseases. 33(3). 337–346.
11.
Richter, Sandra S., John A. Branda, Carey‐Ann D. Burnham, et al.. (2013). Identification of Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using the VITEK MS system. European Journal of Clinical Microbiology & Infectious Diseases. 32(12). 1571–1578.
12.
Branda, John A., Jenna Rychert, Carey‐Ann D. Burnham, et al.. (2013). Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria. Diagnostic Microbiology and Infectious Disease. 78(2). 129–131.
13.
Rychert, Jenna, Carey‐Ann D. Burnham, Maureen Bythrow, et al.. (2013). Multicenter Evaluation of the Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry System for Identification of Gram-Positive Aerobic Bacteria. Journal of Clinical Microbiology. 51(7). 2225–2231.
14.
Westblade, Lars F., Rebecca Jennemann, John A. Branda, et al.. (2013). Multicenter Study Evaluating the Vitek MS System for Identification of Medically Important Yeasts. Journal of Clinical Microbiology. 51(7). 2267–2272.
15.
Mochon, A. Brian, Omai B. Garner, Janet A. Hindler, et al.. (2011). New Delhi Metallo-β-Lactamase (NDM-1)-Producing Klebsiella pneumoniae: Case Report and Laboratory Detection Strategies. Journal of Clinical Microbiology. 49(6). 2386–2386.
16.
Mochon, A. Brian, Omai B. Garner, Janet A. Hindler, et al.. (2011). New Delhi Metallo-β-Lactamase (NDM-1)-Producing Klebsiella pneumoniae: Case Report and Laboratory Detection Strategies. Journal of Clinical Microbiology. 49(4). 1667–1670.
17.
Mochon, A. Brian, Ye Jin, Matthew A. Kayala, et al.. (2010). Correction: Serological Profiling of a Candida albicans Protein Microarray Reveals Permanent Host-Pathogen Interplay and Stage-Specific Responses during Candidemia. PLoS Pathogens. 6(9).
18.
Mochon, A. Brian, Jin Y, Matthew A. Kayala, et al.. (2010). Serological Profiling of a Candida albicans Protein Microarray Reveals Permanent Host-Pathogen Interplay and Stage-Specific Responses during Candidemia. PLoS Pathogens. 6(3). e1000827–e1000827.
19.
Mochon, A. Brian & Haoping Liu. (2008). The Antimicrobial Peptide Histatin-5 Causes a Spatially Restricted Disruption on the Candida albicans Surface, Allowing Rapid Entry of the Peptide into the Cytoplasm. PLoS Pathogens. 4(10). e1000190–e1000190.
20.
Mochon, A. Brian & Jim E. Cutler. (2005). Prospects of vaccines for medically important fungi Is a vaccine needed againstCandidaalbicans?. Medical Mycology. 43(2). 97–115.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Emily K. Crispell Breakdown of academic impact, for papers by Ellen C. Brouwer Breakdown of academic impact, for papers by Matthias Marschal Breakdown of academic impact, for papers by Bianca Graves Breakdown of academic impact, for papers by Marta Mollerach Breakdown of academic impact, for papers by Fevronia Kolonitsiou Breakdown of academic impact, for papers by Magali Dodémont Breakdown of academic impact, for papers by Michael Malczynski Breakdown of academic impact, for papers by Hidemasa Nakaminami Breakdown of academic impact, for papers by Tai-Fen Lee